Type of Care:
Substance use treatment
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Outpatient Outpatient methadone/buprenorphine or naltrexone treatment Regular outpatient treatment
Opioid Medications used in Treatment:
Buprenorphine used in Treatment Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment:
Does not treat alcohol use disorder
Type of Opioid Treatment:
Buprenorphine maintenance Prescribes buprenorphine Lofexidine or Clonidine detoxification Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies:
Buprenorphine with naloxone Naltrexone (oral) Medications for HIV treatment Medications for Hepatitis C treatment Clonidine
Treatment Approaches:
Community reinforcement plus vouchers Relapse prevention Substance use disorder counseling Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public):
Private for-profit organization
License/Certification/Accreditation:
SAMHSA certification for opioid treatment program (OTP)
Assessment/Pre-treatment:
Comprehensive mental health assessment Comprehensive substance use assessment Outreach to persons in the community Complete medical history/physical exam Screening for substance use Screening for mental disorders
Testing:
Drug or alcohol urine screening HIV testing STD testing Metabolic syndrome monitoring Testing for Hepatitis B (HBV) Testing for Hepatitis C (HCV)
Transitional Services:
Naloxone and overdose education
Recovery Support Services:
Assistance with obtaining social services
Education and Counseling Services:
HIV or AIDS education, counseling, or support Hepatitis education, counseling, or support Substance use disorder education Individual counseling
Facility Smoking Policy :
Smoking permitted in designated area
Age Groups Accepted:
Adults Seniors
Facility Vaping Policy:
Vaping permitted in designated area
Ancillary Services:
Integrated primary care services